CoChat

Drp1-dependent mitophagy protects against cisplatin-induced apoptosis of renal tubular epithelial cells by improving mitochondrial function

Open access
Zhao, Chuanyan, Chen, Zhuyun, Qi, Jia, Duan, Suyan, Huang, Zhimin, Zhang, Chengning, Wu, Lin, Zeng, Ming, Zhang, Bo, Wang, Ningning, Mao, Huijuan, Zhang, Aihua, Xing, Changying, Yuan, Yanggang · 2017 · Oncotarget
Cited by 98

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

// Chuanyan Zhao 1, * , Zhuyun Chen 1, * , Jia Qi 2 , Suyan Duan 1 , Zhimin Huang 1 , Chengning Zhang 1 , Lin Wu 1 , Ming Zeng 1 , Bo Zhang 1 , Ningning Wang 1 , Huijuan Mao 1 , Aihua Zhang 3, 4 , Changying Xing 1 , Yanggang Yuan 1 1 Department of Nephrology, the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China 2 Department of Pharmacy, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China 3 Department of Nephrology, Nanjing Children's Hospital, Nanjing Medical University, Nanjing, China 4 Institute of Pediatrics, Nanjing Medical University, Nanjing, China * These authors are contributed equally to this work Correspondence to: Yanggang Yuan, email: ygyuan@njmu.edu.cn Changying Xing, email: cyxing1962@163.com Keywords: Drp1, mitophagy, mitochondrial dysfunction, mitochondrial fission, cisplatin Received: July 10, 2016 Accepted: February 07, 2017 Published: February 18, 2017 ABSTRACT Cisplatin chemotherapy often causes acute kidney injury (AKI) in cancer patients. There is increasing evidence that mitochondrial dysfunction plays an important role in cisplatin-induced nephrotoxicity. Degradation of damaged mitochondria is carried out by mitophagy. Although mitophagy is considered of particular importance in protecting against AKI, little is known of the precise role of mitophagy and its molecular mechanisms during cisplatin-induced nephrotoxicity. Also, evidence that activation of mitophagy improved mitochondrial function is lacking. Furthermore, several evidences have shown that mitochondrial fission coordinates with mitophagy. The aim of this study was to investigate whether activation of mitophagy protects against mitochondrial dysfunction and renal proximal tubular cells injury during cisplatin treatment. The effect of mitochondrial fission on mitophagy was also investigated. In cultured human renal proximal tubular cells, we observed that 3-methyladenine, a pharmacological inhibitor of autophagy, blocked mitophagy and exacerbated cisplatin-induced mitochondrial dysfunction and cells injury. In contrast, autophagy activator rapamycin enhanced mitophagy and protected against the harmful effects of cisplatin on mitochondrial function and cells viability. Suppression of mitochondrial fission by knockdown of its main regulator dynamin-related protein-1 (Drp1) decreased cisplatin-induced mitophagy. Meanwhile, Drp1 suppression protected against cisplatin-induced cells injury by inhibiting mitochondrial dysfunction. Our results provide evidence that Drp1-depedent mitophagy has potential as renoprotective targets for the treatment of cisplatin-induced AKI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.15470

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

Metadata

Authors
Zhao, C., Chen, Z., Qi, J., Duan, S., Huang, Z., Zhang, C., Wu, L., Zeng, M., Zhang, B., Wang, N., Mao, H., Zhang, A., Xing, C., & Yuan, Y.
Venue
Oncotarget
Published
2017-02-18
Volume
8
Issue
13
Pages
20988-21000
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2591482038
Cited by
98
References
12
FWCI
8.90
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.